News by topic

Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Treatment interruptions news

Show

From To
HIV treatment for children and young people
Following an HIV treatment interruption, most children recover immunologically

Just over one in ten (12%) children and adolescents living with HIV in Europe and Thailand take a break from antiretroviral treatment, usually as a result of

Published
07 June 2019
By
Carole Leach-Lemens
Clinical trials
Analytical treatment interruptions: minimising the risks and maximising their scientific value

Recommendations for the safe and appropriate use of ‘analytical treatment interruptions’ have been developed by a group of HIV experts, including clinicians, patient advocates, bioethicists, social scientists and

Published
15 May 2019
By
Alain Volny-Anne
Treatment interruptions
HIV-positive participant in vaccine study passes virus to sexual partner during treatment interruption

An HIV-positive man transmitted HIV to his sexual partner after interrupting antiretroviral therapy as part of a research study into a therapeutic vaccine, French scientists reported in

Published
01 March 2019
By
Roger Pebody
Treatment outcomes and life expectancy
Atripla or efavirenz plus Truvada failed one in 16 people in first year

Although analyses of the failure rate of ART have been conducted before, a new analysis is the first to compute these rates for a single-drug regimen

Published
21 January 2019
By
Gus Cairns
Treatment interruptions
Community Recommendations for Clinical Research Involving Antiretroviral Treatment Interruptions in Adults

Scientists working to develop a cure for HIV infection sometimes need to conduct clinical trials in which participants are asked to temporarily interrupt ART, which contradicts the recommendations and guidelines for people with HIV under medical care.

Published
15 November 2018
From
TAG
Undetectable viral load and treatment as prevention
Viral load in semen rapidly rebounds to infectious levels during HIV treatment breaks

Viral load rebounds rapidly in semen to potentially infectious levels following interruption of combination antiretroviral therapy (cART), according to French research published in AIDS.Increases in viral load in both

Published
14 November 2018
By
Michael Carter
Treatment interruptions
One in nine people may be able to control their viral load after stopping treatment, US study finds

A US collaboration that pooled data from 14 scientific studies containing between them more than 600 HIV-positive people has found that 67 of them were able to

Published
16 August 2018
By
Gus Cairns
Access to medicines and treatment
Antiretroviral shortage reaches 100% in Venezuela

Alberto Nieves, executive director of Acción Ciudadana Contra el SIDA (ACCSI) says: "By March 2018, the shortage of antiretroviral drugs reached 100% in Venezuela, which It is affecting more than 80 thousand people with HIV." Four of the 27 licensed antiretrovirals were still in stock but not ones necessary to construct viable combination therapy.

Published
17 April 2018
From
Corresponsales Clave
The search for a cure
Is It Ethical to Take People Off HIV Meds for Cure Research?

Cure studies typically require a temporary break in HIV treatment, often with little promise of a personal benefit to the participant.

Published
13 September 2017
From
Poz
The search for a cure
VRC01 antibody can delay but not prevent viral rebound after interruption of early treatment

A broadly neutralising antibody modestly delayed the resurgence of viral replication following interruption of antiretroviral therapy (ART) started during very early infection, but all study participants ultimately experienced

Published
02 August 2017
By
Liz Highleyman
← First12345...10Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.